Literature DB >> 31310287

Price Increases of Protected-Class Drugs in Medicare Part D, Relative to Inflation, 2012-2017.

Thomas J Hwang1, Stacie B Dusetzina2, Josh Feng3, Luca Maini4, Aaron S Kesselheim5.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31310287      PMCID： PMC6635901          DOI： 10.1001/jama.2019.7521

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA.

Authors:  Kayla Engelbrecht; Srinjoy Roy; Gorana Capkun; Kristijan Kahler; Melvin Olson
Journal:  J Comp Eff Res       Date:  2022-06-14       Impact factor: 2.040

2.  Coverage of New Drugs in Medicare Part D.

Authors:  Huseyin Naci; Ilias Kyriopoulos; William B Feldman; Thomas J Hwang; Aaron S Kesselheim; Amitabh Chandra
Journal:  Milbank Q       Date:  2022-05-03       Impact factor: 6.237

3.  Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017.

Authors:  Joshua J Skydel; Alexander C Egilman; Joshua D Wallach; Reshma Ramachandran; Ravi Gupta; Joseph S Ross
Journal:  JAMA Health Forum       Date:  2022-05-27

4.  Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.

Authors:  VÉronique C Raimond; William B Feldman; Benjamin N Rome; Aaron S Kesselheim
Journal:  Milbank Q       Date:  2021-03       Impact factor: 6.237

5.  The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analysis in a large tertiary hospital in China.

Authors:  Yuan-Jin Zhang; Yan Ren; Quan Zheng; Jing Tan; Ming-Hong Yao; Yun-Xiang Huang; Xia Zhang; Kang Zou; Shao-Yang Zhao; Xin Sun
Journal:  Front Public Health       Date:  2022-08-12

6.  Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis.

Authors:  Chien-Wen Tseng; R Adams Dudley; Randi Chen; Rochelle P Walensky
Journal:  JAMA Netw Open       Date:  2020-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.